Skip to main content

Table 3 Cancer-Specific Survival according to treatment and risk groups to 7 years

From: Intensity-modulated radiotherapy versus radical prostatectomy in patients with localized prostate cancer: long-term follow-up

Cancer-specific survival   7 years (%) 95% CI p value
All patients RP 98.1 0.968-0.989 <0.001
IMRT 92.1 0.858-0.957
Low risk RP 99.3 0.951-0.999 0.089
IMRT 97.4 0.825-0.996
Intermediate risk RP 99.6 0.983-0.999 0.003
IMRT 94.1 0.823-0.981
High risk RP 93.0 0.878-0.960 0.07
IMRT 85.4 0.704-0.932